PBMs and Patient Access | The Conversation Continues

Terry Wilcox is the co-founder and Chief Mission Officer of Patients Rising. She has spent more than a decade advancing patient-centered healthcare policy — bringing patient perspectives into legislative, regulatory, and public discourse. She regularly moderates policy discussions that bring together patients, economists, clinicians, and industry leaders.

David is president and CEO of PCMA.

Prior to joining PCMA, David served as Global Head of Government Affairs, Public Policy, and Advocacy with global pharmaceutical company Viatris. He is a veteran public affairs leader known for his sophisticated understanding of the intersections of policy, politics, and business. David has earned a reputation as a persuasive storyteller, guiding industries and organizations as they position themselves as trusted thought leaders.

He was previously Managing Principal of the Podesta Group, a leading Washington, D.C. public affairs firm, where he launched the strategic communications practice and led the firm’s advocacy work for dozens of clients, including Deloitte, Mylan, the Blue Cross Blue Shield Association, CrossFit, the golf industry, BP, Wells Fargo, and many others.

David was previously the Staff Director of the House Oversight and Government Reform Committee and also served as the Staff Director of the Select Committee that investigated the government’s response to Hurricane Katrina.

As Chief Government Affairs Officer at the Pharmaceutical Care Management Association (PCMA), Lucia Lebens leads the organization's bipartisan engagement strategy with federal and state elected officials, regulatory agencies, and key policymakers — with a focus on shaping federal and state policies that impact the pharmaceutical care industry.

With over 20 years of experience in government relations and public policy across the healthcare, education, and financial services sectors, Lucia brings deep expertise in advancing complex legislative priorities through strategic, collaborative advocacy. Prior to PCMA, she served as Vice President of Government Relations & Public Policy at Navient, Director of Federal Government Affairs at ACA International, and Deputy Chief of Staff for a U.S. Senator.

Recognized as a Top Lobbyist by The Hill four consecutive years — 2022, 2023, 2024, and 2025 — and named among Washingtonian Magazine's 500 Most Influential People Shaping Policy in Washington in both 2025 and 2026, Lucia thrives on building coalitions, driving meaningful policy change, and supporting the goals of PCMA and the broader industry.

Brendan is Chief Communications Officer of PCMA.

Brendan Buck joined PCMA from Seven Letter, a public affairs agency, where he was partner and specialized in health sector clients, leading numerous health care campaigns. Alongside his consulting work, Brendan was an on-air political analyst for NBC News and MSNOW, as well as a contributing opinion writer for the New York Times.

Brendan spent more than a decade on Capitol Hill. He was counselor to House Speaker Paul Ryan, leading messaging and communications strategy for the speaker and the broader House Republican leadership team. Earlier, Brendan served as communications director at the House Ways and Means Committee, with its jurisdiction over tax, trade, and health care policy.

Brendan earlier was vice president for communications at America’s Health Insurance Plans. At AHIP, he was the insurance industry’s top spokesman and drove a major campaign on health care affordability.

Prior to that, Brendan was press secretary to House Speaker John Boehner. Brendan was also on the 2012 Romney-Ryan presidential campaign, serving as press secretary to the Vice President nominee. He held several other senior communications roles on Capitol Hill, including for later-Speaker Kevin McCarthy and former Rep. Tom Price.

Tim Dube has been with PCMA for seven years, and oversees the association’s policy and federal regulatory work. He came to PCMA with a deep history of experience in pharmaceutical and biotechnology policy issues.

Prior to joining PCMA, Tim worked as a senior policy analyst within the US Department of Health and Human Services’ Office of the Assistant Secretary for Planning and Evaluation (ASPE). Previous to ASPE, Tim worked for 11 years with Genentech, in various roles spanning from drug development to commercialization to state and federal policy, and at Optum consulting with biopharmaceutical clients on drug safety.

Tim graduated with a B.A. in Political Science from Boston College and an M.P.H. focused on Biostatistics from the Boston University School of Public Health.

Amanda Frost is Vice President, Research at PCMA, as well as the Vice President, PCMA Foundation. In these roles she oversees all the internal and external research for the organization.

Prior to joining PCMA, Amanda was a Senior Researcher at the Health Care Cost Institute, specializing in the analysis of big health care data. She has a MA and PhD in Political Science from the University of Iowa.